目的探讨在择期经皮冠状动脉介入（PCI）治疗中静脉应用伊诺肝素的有效性和安全性以及与普通肝素对比的疗效差别。
Objective To investigate the effectiveness and safety of intravenous enoxaparin application in PCI and its therapeutic effect compared with unfractionated heparin.
不管是否服用氯吡格雷，依诺肝素都较普通肝素具有更明显的安全性和有效性。
The significantly improved safety and efficacy profile of enoxaparin versus unfractionated heparin was maintained regardless of clopidogrel administration.
这些研究比较了血液稀释剂普通肝素和安慰剂、低分子肝素和安慰剂或是两种肝素之间的作用比较。
The studies compared the blood-thinner unfractionated heparin to a placebo, or low-molecular-weight heparin with a placebo, or both types of heparin with each other.
结论：与标准剂量的普通肝素相比，低剂量普通肝素不能减少主要的PCI相关的出血和血管穿刺点并发症的发生。
Conclusion Low-dose compared with standard-dose unfractionated heparin did not reduce major peri-PCI bleeding and vascular access-site complications.
因此，血液灌流抢救急性药物中毒的抗凝方法中低分子肝素钙明显优于无肝素法和普通肝素法。
We conclude that low molecular heparinate is superior to the other methods for anticoagulation in emergence treatment of acute p…
因此，血液灌流抢救急性药物中毒的抗凝方法中低分子肝素钙明显优于无肝素法和普通肝素法。
We conclude that low molecular heparinate is superior to the other methods for anticoagulation in emergence treatment of acute p…
应用推荐